Cite
MLA Citation
J. Rosenberg et al.. “21LBA Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210).” European journal of cancer, vol. 51, n.d., pp. S720–. http://access.bl.uk/ark:/81055/vdc_100030687872.0x000063